PennantPark Investment Research and Development Expenses 2010-2024 | PNNT

PennantPark Investment research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
PennantPark Investment Annual Research and Development Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
PennantPark Investment Quarterly Research and Development Expenses
(Millions of US $)
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Finance Finance - SBIC & Commercial $0.483B $0.145B
PennantPark Investment Corporation is a business development company which principally invests in U.S. middle-market private companies in the form of mezzanine debt, senior secured loans and equity investments. The companies in which it invests are typically highly leveraged, often as a result of leveraged buy-outs or other recapitalization transactions. PennantPark's investment objectives are to generate both current income and capital appreciation through debt and equity investments. PennantPark Investment Corporation is managed by PennantPark Investment Advisers, LLC.
Stock Name Country Market Cap PE Ratio
Ares Capital (ARCC) United States $13.120B 8.93
Blackstone Secured Lending Fund (BXSL) United States $5.948B 8.05
FS KKR Capital (FSK) United States $5.632B 6.57
Main Street Capital (MAIN) United States $4.161B 11.37
Hercules Capital (HTGC) United States $3.148B 9.20
Golub Capital BDC (GBDC) United States $2.787B 8.33
Morgan Stanley Direct Lending Fund (MSDL) United States $1.957B 8.20
Goldman Sachs BDC (GSBD) United States $1.705B 6.58
New Mountain Finance (NMFC) United States $1.338B 8.12
BARINGS BDC, INC (BBDC) United States $1.054B 8.22
Bain Capital Specialty Finance (BCSF) United States $1.044B 7.28
Nuveen Churchill Direct Lending (NCDL) United States $0.968B 0.00
BLACKROCK TCP CAPITAL CORP (TCPC) United States $0.927B 5.82
Carlyle Secured Lending (CGBD) United States $0.910B 8.37
SLR Investment (SLRC) United States $0.889B 9.47
Amalgamated Financial (AMAL) United States $0.772B 8.35
Trinity Capital (TRIN) United States $0.731B 6.75
CION Investment (CION) United States $0.669B 6.31
Crescent Capital BDC (CCAP) United States $0.667B 7.53
Fidus Investment (FDUS) United States $0.628B 7.83
Palmer Square Capital BDC (PSBD) United States $0.547B 0.00
Gladstone Investment (GAIN) United States $0.509B 14.01
Gladstone Capital (GLAD) United States $0.485B 11.31
Runway Growth Finance (RWAY) United States $0.469B 6.12
Horizon Technology Finance (HRZN) United States $0.409B 6.15
TriplePoint Venture Growth BDC (TPVG) United States $0.358B 4.86
Stellus Capital Investment (SCM) United States $0.335B 7.15
Saratoga Investment Corp (SAR) United States $0.324B 5.76
WhiteHorse Finance (WHF) United States $0.308B 7.16
Medallion Financial (MFIN) United States $0.185B 3.73
Oxford Square Capital (OXSQ) United States $0.184B 6.43
OFS Capital (OFS) United States $0.133B 6.38
PhenixFIN (PFX) United States $0.091B 17.47
Silver Spike Investment (SSIC) United States $0.071B 13.54
Advanced Medical Isotope (RDGL) United States $0.060B 0.00
Logan Ridge Finance (LRFC) United States $0.060B 16.19
Investcorp Credit Management BDC (ICMB) United States $0.046B 5.85
Rand Capital (RAND) United States $0.000B 12.09